EP4719384A2 - Verbindungen mit antimykotischen eigenschaften - Google Patents
Verbindungen mit antimykotischen eigenschaftenInfo
- Publication number
- EP4719384A2 EP4719384A2 EP24816202.6A EP24816202A EP4719384A2 EP 4719384 A2 EP4719384 A2 EP 4719384A2 EP 24816202 A EP24816202 A EP 24816202A EP 4719384 A2 EP4719384 A2 EP 4719384A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- mbx
- alkyl
- compound
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363469306P | 2023-05-26 | 2023-05-26 | |
| PCT/US2024/030955 WO2024249290A2 (en) | 2023-05-26 | 2024-05-24 | Compounds with antifungal properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4719384A2 true EP4719384A2 (de) | 2026-04-08 |
Family
ID=93658858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP24816202.6A Pending EP4719384A2 (de) | 2023-05-26 | 2024-05-24 | Verbindungen mit antimykotischen eigenschaften |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4719384A2 (de) |
| CN (1) | CN121218986A (de) |
| AU (1) | AU2024281873A1 (de) |
| WO (1) | WO2024249290A2 (de) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004033427A1 (en) * | 2002-10-11 | 2004-04-22 | Astrazeneca Ab | 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors |
| GB0623209D0 (en) * | 2006-11-21 | 2007-01-03 | F2G Ltd | Antifungal agents |
-
2024
- 2024-05-24 CN CN202480035333.XA patent/CN121218986A/zh active Pending
- 2024-05-24 WO PCT/US2024/030955 patent/WO2024249290A2/en not_active Ceased
- 2024-05-24 EP EP24816202.6A patent/EP4719384A2/de active Pending
- 2024-05-24 AU AU2024281873A patent/AU2024281873A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN121218986A (zh) | 2025-12-26 |
| WO2024249290A2 (en) | 2024-12-05 |
| AU2024281873A1 (en) | 2025-12-11 |
| WO2024249290A3 (en) | 2025-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI660671B (zh) | 用於穀類中之真菌控制的協同性殺真菌混合物 | |
| US11065228B2 (en) | Antifungal agents | |
| ES2807849T3 (es) | Derivados de oxadiazol microbicidas | |
| ES2534516T3 (es) | Compuestos heterocíclicos fungicidas | |
| DK2485592T3 (en) | Synergistic fungicidal compounds for mushrooms fight in cereals | |
| CN106061259B (zh) | 用于谷类中真菌防治的协同杀真菌混合物 | |
| ES2842550T3 (es) | Derivados de tiazol microbiocidas | |
| ES2643082T3 (es) | Fungicidas de benceno sustituido | |
| ES2712668T3 (es) | Composiciones fungicidas sinérgicas | |
| CN104023540A (zh) | 具有杀线虫活性的化合物 | |
| BR112020000463A2 (pt) | derivados oxadiazol microbiocidas | |
| EP4719384A2 (de) | Verbindungen mit antimykotischen eigenschaften | |
| KR101620377B1 (ko) | 항진균제로서 사용하기 위한 이차 8-히드록시퀴놀린-7-카르복사미드 유도체 | |
| RS63746B1 (sr) | Antifungalni agensi sa pojačanom aktivnošću u kiseloj ph | |
| EA020487B1 (ru) | Новые вторичные производные 8-оксихинолин-7-карбоксамида | |
| TWI721015B (zh) | 角膜真菌症之預防或治療劑 | |
| CN115594641A (zh) | 一类含苄基1,2,3-三唑结构的化合物及其作为杀菌剂的应用 | |
| ES2810752T3 (es) | Derivados de oxadiazol microbicidas | |
| JP2017214366A (ja) | ヒドラゾン化合物及び有害生物防除剤 | |
| WO2024163405A1 (en) | Boron containing compounds and their uses | |
| CN113616641A (zh) | 3-苯基吲哚衍生物制备抗真菌药物的应用 | |
| WO2025149010A1 (zh) | 吡咯类化合物及其应用 | |
| JP2024120189A (ja) | チエノウラシル化合物及び有害生物防除剤 | |
| HK1242316A1 (en) | Antifungal agents | |
| HK1242316B (en) | Antifungal agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20251210 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |